Cell Adhesion Assays Products & Reviews

BioReagent, powder, suitable for cell culture  

For robust organoid cultures - Reduced Growth Factor Basement Membrane Extract

Fluorescent immunoassay analyzer

Medical grade, virgin PP, non treated. The large well diameter of Biotix 96-well assay plates make them ideal for a broad range of applications, including compound libraries and combinatorial chemistry. Available with either V-shaped or U-shaped well bottom to suit assay needs.

Multi-analyte controls in diluent that mimics human CSF. The concentrations of the analytes are provided in the lot-specific certificate of analysis.

Chemical Name: (RS)-3,5-Dihydroxyphenylglycine Selective group I metabotropic glutamate receptor agonist which activates both mGlu1 and mGlu5. Also reported to be an antagonist at metabotropic glutamate receptors linked to phospholipase D. Selective group I mGlu agonist.

µ-Slide for stable gradients, 3 chambers on one slide for chemotaxis and migration assays• long term chemotaxis experiments with adherent cells• ready to use system, no assembling• linear gradients, stable for over 48 hours• 3 chambers on one slide for parallel working• adapters for different pipettes• made for high-end video microscopybasic principle: two large reservoirs of 40µl are connected by a narrow observation areathe…

Incucyte® Proliferation Assays for Live-Cell Analysis

Monitor adherent cell morphology changes objectively to determine live/dead cell counts or classify cells based on morphology via label-free multivariate analysis

The cloud-based Cytobank data analysis platform is an ideal solution for immunologists and cytometrists who need to quickly gain insights from large datasets while having confidence in their results, reducing subjectivity of their analysis and eliminating error-prone and time-consuming steps.

PromoCell introduces the next generation 3D Tumorsphere Medium. This medium has been designed to meet your requirements for the extended serial culture of tumospheres. Our 3D Tumorsphere Medium supports the culture of the most commonly used cancer cell lines.

Automated, multi-plate, live-cell analysis platform

Svar specializes in creating cell-based Reporter Gene Assays with iLite® technology for a range of applications. This technology offers a precise, sensitive system with luciferase readout, suitable for testing drug activity, immunogenicity, and Fc-functional assays including CDC, ADCC, and ADCP activity. Svar's development capabilities cover nearly any pharmaceutical target, ensuring rapid and accurate assays.

Svar specializes in creating cell-based Reporter Gene Assays with iLite® technology for a range of complement applications. This technology offers a precise, sensitive system with luciferase readout, suitable for assessing drug activity for different targets such as C5a, and through Complement-Dependent Cytotoxicity (CDC) activity.

The iLite® C5a Assay Ready Cells can be used for the quantification of C5a activity, and for determination of inhibitory activity against either C5a itself or against the C5a receptor in test samples, including human serum.

With their proprietary technology, the iLite® technology Svar can develop Report Gene Assays – that area cleverly designed, sensitive and specific cell based reporter-gene system with luciferase readout. Svar can develop assays for virtually any pharmaceutical target that allow an easy, rapid and accurate test format for a wide range of applications, such as Immunogenicity and Potency assays.

The iLite® Functional Bioassay portfolio consists of cell lines provided in an “assay-ready” format for a rapid and convenient workflow. The assay-ready format also reduces assay variability, optimizing its use in screening, characterization, stability, and potency studies. iLite cell lines can be tailored to virtually any biopharmaceutical target.

The iLite® Fc Effector Reporter Gene Bioassays Portfolio offers a variety of reporter gene cell lines and target cells that can be used in MOA-reflective assays to measure the Fc effect of antibodies and other biologics that specifically bind and activate Fc receptors. Using a Luciferase reporter gene system offers a convenient and powerful way of measuring antibodies' in vitro efficacy in triggering ADCC and ADCP.

Svar offers assistance in gene therapy projects through robust platforms suited for all phases of drug development and experience from immunoassasy product development as well as their CRO services. Svar currently offer cell-based assays for Neutralizing antibody assessment and custom-made immunoassays for Total antibody assessment.

Complement biomarker assays target selected biomarkers of high relevance. These assays are important and well-suited for analyses in drug development and academic research. They stand out with very low cross-reactivity and high specificity as they bind neo-epitopes of cleaved products or complexes, where this is relevant.

In diagnosis of Rheumatoid Arthritis (RA), the measurement of anti-CCP is integral. People who test positive for Anti-CCP, are very likely to develop or have already developed RA, but not all who have RA, necessarily develop anti-CCP. Early detection of RA is crucial for reducing tissue damage.

Calpro, a Svar subsidiary, produced the first ever commercial kits available for measuring Calprotectin setting industry standards. It offers a broad range of assays, including ELISA, PETIA (Turbidimetric assay), and rapid Point-of-Care (PoC) and self-tests for IBD monitoring. Calpro also provides RUO ELISAs for various bodily fluids and a rapid CalproSmart test as an RUO product.

Svar CRO Services provides direct value through an extensive toolbox of in-house products, scientific expertise, and end-to-end customizable solutions – everything to ensure the success of your drug development program.​

The Wieslab® Complement System Classical Pathway kit, available as IVD* and RUO, is a high-precision assay for detecting alternative complement pathway activity in human serum, the RUO is also suitable for primates and porcine samples. It uses ELISA technology with specific detection of C5b-9 for accurate results, offering advantages over traditional assays. *Subject to local registration.

The Wieslab® Complement System MBL Pathway kit, available as IVD* and RUO, is a high-precision assay for detecting alternative complement pathway activity in human serum, the RUO is also suitable for primates and porcine samples. It uses ELISA technology with specific detection of C5b-9 for accurate results, offering advantages over traditional assays. *Subject to local registration.